Insights On Upstream Manufacturing

  1. From Gene Editing To NGS-Based T Cell Characterization 6/4/2026

    Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

  2. Faster Clones, Simpler Process: What's Changing In CHO Expression? 6/3/2026

    This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

  3. End-To-End Process Scalability Of HEK 293 Media For High Titer AAV Production 6/2/2026

    Explore how controlled bioreactor environments enable optimization of critical process parameters and support robust, scalable AAV production from development through manufacturing.

  4. Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing 6/2/2026

    See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.

  5. Asahi Kasei Bioprocess - Made In The USA 5/29/2026

    Discover how combining Japanese precision with American ingenuity creates reliable bioprocess filtration solutions built for consistent, batch-after-batch manufacturing performance.

  6. Microbial Expertise That Scales Globally 5/28/2026

    Want consistency and control in microbial manufacturing? We combine decades of expertise, advanced automation, and global processes to deliver reliable, scalable fermentation performance.

  7. Scaling Success With Perfusion Manufacturing 5/28/2026

    Interested in improving cell viability in biologics manufacturing? See how perfusion processes help maintain healthier cell cultures by continuously removing waste products.

  8. How Integrated Molecule Innovation Is Transforming Vet Therapeutics 5/27/2026

    Cell line development underpins modern animal health innovation, enabling production of targeted biologics and supporting integrated approaches that improve therapeutic precision, scalability, and treatment outcomes.

  9. Reducing Variability In Gene Expression: Bottlenecks And Solutions 5/26/2026

    Gene expression variability in biologics comes from random gene integration and cell heterogeneity; advanced engineering and targeted integration improve consistency, stability, and productivity.

  10. Cell Line Development: Faster Path To A Stable Master Cell Bank 5/26/2026

    Cell line development builds stable, high-yield cell lines and a master cell bank, enabling consistent, scalable biologics manufacturing through selection, characterization, and cryopreservation.